×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

  • Gurus
  • Other
  • RA CAPITAL MANAGEMENT, L.P. (Data extracted from 13F, 13D, 13G and Form 4)

RA CAPITAL MANAGEMENT, L.P.

AUM: $11.32 B
13-F Portfolio Value: $5.94 B
Last 13-F Filed: Q2 2025
Concentration in top 10: 66.19%
Filter by:
Quarter to View:
Stock Company % Portfolio Shares Held Market Value Change in Shares % Change Quarter End Price Source
ACRSACLARIS THERAPEUTICS INC-4,666,667Exited13F
AVTEAEROVATE THERAPEUTICS INC-9,192,092Exited13F
ALECALECTOR INC-9,695,228Exited13F
APGEAPOGEE THERAPEUTICS INC-1,569,491Exited13F
ATXSASTRIA THERAPEUTICS INC-5,105,213Exited13F
BCYCBICYCLE THERAPEUTICS PLC-ADR-1,093,477Exited13F
BIOABIOAGE LABS INC-1,052,494Exited13F
BOLDBOUNDLESS BIO INC-2,180,631Exited13F
DRUGBright Minds Biosciences Inc-206,427Exited13F
CBLLCERIBELL INC-824,582Exited13F
DAWNDAY ONE BIOPHARMACEUTICALS I-5,755,577Exited13F
EYPTEYEPOINT PHARMACEUTICALS INC-3,181,818Exited13F
GKOSGLAUKOS CORP-190,256Exited13F
HUMAHUMACYTE INC-3,312,356Exited13F
IDYAIDEAYA BIOSCIENCES INC-1,347,252Exited13F
INSMINSMED INC-200,000Exited13F
ITOSITEOS THERAPEUTICS INC-3,649,057Exited13F
KURAKURA ONCOLOGY INC-4,004,610Exited13F
LXEOLEXEO THERAPEUTICS INC-546,554Exited13F
NRIXNURIX THERAPEUTICS INC-1,333,333Exited13F
SCLXSCILEX HOLDING CO-1,036,218Exited13F
SERASERA PROGNOSTICS INC-A-3,032,808Exited13F
STROSUTRO BIOPHARMA INC-4,434,637Exited13F
XNCRXENCOR INC-575,000Exited13F
ZLABZAI LAB LTD-ADR-1,295,040Exited13F
ZURAZURA BIO LTD-3,217,503Exited13F
URGNUROGEN PHARMA LTD-3,206,271Exited13F
IMTXIMMATICS NV-1,750,000Exited13F